CME Group’s (CME) Buy Rating Reaffirmed at Oppenheimer

Oppenheimer reiterated their buy rating on shares of CME Group (NASDAQ:CME) in a report published on Wednesday, AnalystRatings.com reports.

A number of other equities research analysts also recently issued reports on CME. Rosenblatt Securities cut their target price on shares of CME Group from $153.00 to $152.00 and set a sell rating for the company in a research report on Wednesday, June 3rd. Barclays reiterated a buy rating and issued a $200.00 target price on shares of CME Group in a research report on Tuesday, April 14th. Cfra cut their target price on shares of CME Group from $218.00 to $205.00 and set a hold rating for the company in a research report on Wednesday, April 29th. Credit Suisse Group cut their target price on shares of CME Group from $190.00 to $183.00 and set a neutral rating for the company in a research report on Tuesday, June 23rd. Finally, Zacks Investment Research upgraded shares of CME Group from a hold rating to a buy rating and set a $182.00 target price for the company in a research report on Monday, April 6th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. CME Group currently has a consensus rating of Hold and an average price target of $187.88.

CME Group stock opened at $166.18 on Wednesday. The company has a 50 day moving average price of $169.99 and a 200 day moving average price of $186.20. CME Group has a 52 week low of $131.80 and a 52 week high of $225.36. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.01 and a current ratio of 1.02. The firm has a market capitalization of $59.59 billion, a price-to-earnings ratio of 25.06, a P/E/G ratio of 5.02 and a beta of 0.30.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 29th. The financial services provider reported $1.63 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.01. CME Group had a net margin of 46.39% and a return on equity of 9.93%. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same quarter last year, the business posted $1.76 EPS. The company’s revenue was down 7.1% on a year-over-year basis. Equities analysts forecast that CME Group will post 7.04 earnings per share for the current fiscal year.

In related news, Director William R. Shepard purchased 1,229 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were bought at an average cost of $178.10 per share, for a total transaction of $218,884.90. Following the transaction, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $356,200. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard purchased 771 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was bought at an average price of $178.10 per share, for a total transaction of $137,315.10. Following the completion of the transaction, the director now directly owns 771 shares in the company, valued at $137,315.10. The disclosure for this purchase can be found here. Company insiders own 1.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of CME. Redpoint Investment Management Pty Ltd raised its stake in shares of CME Group by 27.8% during the fourth quarter. Redpoint Investment Management Pty Ltd now owns 7,140 shares of the financial services provider’s stock worth $1,433,000 after buying an additional 1,551 shares during the last quarter. Pearl River Capital LLC raised its stake in shares of CME Group by 246.7% during the fourth quarter. Pearl River Capital LLC now owns 1,484 shares of the financial services provider’s stock worth $298,000 after buying an additional 1,056 shares during the last quarter. Macquarie Group Ltd. grew its holdings in CME Group by 14.8% during the fourth quarter. Macquarie Group Ltd. now owns 562,462 shares of the financial services provider’s stock valued at $112,898,000 after purchasing an additional 72,558 shares during the period. Quadrant Capital Group LLC grew its holdings in CME Group by 14.3% during the fourth quarter. Quadrant Capital Group LLC now owns 2,542 shares of the financial services provider’s stock valued at $486,000 after purchasing an additional 318 shares during the period. Finally, Park National Corp OH grew its holdings in CME Group by 10.2% during the first quarter. Park National Corp OH now owns 2,204 shares of the financial services provider’s stock valued at $381,000 after purchasing an additional 204 shares during the period. Institutional investors own 84.83% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How is net asset value different from market price?

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.